11,404
Participants
Start Date
October 31, 2007
Primary Completion Date
July 31, 2008
Study Completion Date
July 31, 2008
Cell culture-derived influenza vaccine
One dose (0.5 mL) of cell culture-derived influenza vaccine, administered in the deltoid muscle.
Egg-derived influenza virus vaccine
One dose (0.5 mL) of the trivalent egg-derived influenza virus vaccine, administered in the deltoid muscle.
Placebo
One dose (0.5 mL) of phosphate buffered solution.
Site 5, Endwell
Site 10, Binghamton
Site 22, Lahti
Site 24, Turku
Site 6, Burke
Site 16, Winston-Salem
Site 23, Pori
Site 12, Anderson
Site 15, Pembroke Pines
Site 21, Tampere
Site 17, South Miami
Site 2, Bardstown
Site 34, Kotka
Site 32, Seinäjoki
Site 1, St Louis
Site 13, Lenexa
Site 35, Kokkola
Site 30, Kuopio
Site 8, Dallas
Site 9, Austin
Site 14, Denver
Site 7, Salt Lake City
Site 3, Salt Lake City
Site 31, Oulu
Site 4, Edison
Site 11, Warwick
Site 25, Espoo
Site 26, Helsinki
Site 27, Helsinki
Site 33, Järvenpää
Site 28, Vantaa
Site 29, Vantaa
Site 49, Bydgoszcz
Site 62, Gmina Końskie
Site 53, Gniewkowo
Site 59, Katowice
Site 63, Kielce
Site 57, Krakow
Site 41, Krakow
Site 43, Krakow
Site 42, Krakow
Site 50, Krakow
Site 44, Lubartów
Site 45, Lublin
Site 65, Oleśnica
Site 47, Olsztyn
Site 48, Olsztyn
Site 46, Olsztyn
Site 58, Radziszów
Site 61, Ruda Śląska
Site 60, Rzeszów
Site 52, Warsaw
Site 54, Wąbrzeźno
Site 55, Wilkowice
Site 64, Wroclaw
Site 51, Łodź
Lead Sponsor
Novartis Vaccines
INDUSTRY